Hypercalcemia of Malignancy

specific

Hypercalcemia due to a tumor production of parathyroid hormone-related protein or 1,25-dihydroxyvitamin D(3), or due to osteolytic metastases with local release of cytokines.

Centers

Active Trials

—

Cancer Funding

Top Centers for Hypercalcemia of Malignancy(15)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Active Trials	Cancer Funding	Score
1	UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive	—	—	53.3
2	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive	—	—	53.3
3	University of Colorado Cancer CenterAurora, CO NCI Comprehensive	—	—	53.3
4	Moffitt Cancer CenterTampa, FL NCI Comprehensive	—	—	53.3
5	Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive	—	—	53.3
6	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive	—	—	53.3
7	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical	—	—	53.3
8	Cleveland Clinic Cancer CenterCleveland, OH	—	—	53.3
9	Georgetown Lombardi Comprehensive Cancer CenterWashington, DC NCI Comprehensive	—	—	53.3
10	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive	—	—	53.3
11	University of Illinois Cancer CenterChicago, IL	—	—	53.3
12	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR	—	—	53.3
13	Boston University Cancer CenterBoston, MA	—	—	53.3
14	Cancer Center at IllinoisUrbana, IL	—	—	53.3
15	Louisiana Cancer Research CenterNew Orleans, LA	—	—	53.3

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →